Times are good for Ginetta right now. The Junior grid is booming (must be handy having Lando Norris as an alumnus), the ...

EXCLUSIVE: Justin Hartley has signed a new multi-year first-look deal with 20th Television through his company, ChangeUp ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

The company trades at 25.6x 2026E EV/EBITDA and 20.6x excluding Nemluvio, representing a 73% and 36% premium, respectively, over Swiss therapeutic peers Straumann and Alcon (NYSE:ALC). UBS continues ...